Covered recipient · General Payments record
ANDREW S FRAZIER
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2018–2024
$31,871.29
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $539.58 | 17 |
| Travel and Lodging | $36.16 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $282.20 | 10 |
| Medtronic, Inc. | $173.02 | 3 |
| Averitas Pharma Inc. | $82.91 | 3 |
| SPR Therapeutics, Inc | $26.65 | 1 |
| Vertos Medical, Inc. | $10.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Averitas Pharma Inc. | $32.41 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426371 | CMS |
| Averitas Pharma Inc. | $26.18 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426375 | CMS |
| Averitas Pharma Inc. | $24.32 | 10/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426377 | CMS |
| Medtronic, Inc. | $111.90 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119540267 | CMS |
| Medtronic, Inc. | $36.16 | 07/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119540269 | CMS |
| Medtronic, Inc. | $24.96 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119540271 | CMS |
| Nevro Corp. | $6.20 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780652 | CMS |
| Nevro Corp. | $4.96 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780654 | CMS |
| Nevro Corp. | $22.13 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780650 | CMS |
| Nevro Corp. | $22.53 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780686 | CMS |
| Nevro Corp. | $131.12 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780680 | CMS |
| Nevro Corp. | $10.69 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780641 | CMS |
| Nevro Corp. | $26.23 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780637 | CMS |
| Nevro Corp. | $20.68 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780684 | CMS |
| Nevro Corp. | $24.64 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780682 | CMS |
| Nevro Corp. | $13.02 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780639 | CMS |
| SPR Therapeutics, Inc | $26.65 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104927471 | CMS |
| Vertos Medical, Inc. | $10.96 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133352986 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.